Abstract: This study is to investigate the inhibitory effect of kaempferol on inflammatory response of lipopolysaccharide(LPS)-stimulated HMC-1 mast cells. The cytotoxicity of kaempferol to HMC-1 mast cells were analyzed by using MTT assay and then the administration concentrations of kaempferol were established. Histamine, IL-6, IL-8, IL-1β and TNF-α were measured using ELISA assay in activated HMC-1 mast cells after incubation with various concentrations of kaempferol (10, 20 and 40 μmol·L^-1). Western blot was used to test the protein expression of p-IKKβ, IkBα, p-IkBα and nucleus NF-κB of LPS-induced HMC-1 mast cells after incubation with different concentrations of kaempferol. The optimal concentrations of kaempferol were defined as the range from 5 μmol·L^-1 to 40 μmol·L^-1. Kaempferol significantly decreased the release of histamine, IL-6, IL-8, IL-1β and TNF-α of activated HMC-1 mast cells (P < 0.01). After incubation with kaempferol, the protein expression of p-IKKβ, p-IκBα and nucleus NF-κB (p65) markedly reduced in LPS-stimulated HMC-1 mast cells (P < 0.01). Taken together, we concluded that kaempferol markedly inhibit mast cell-mediated inflammatory response. At the same time, kaempferol can inhibit the activation of IKKβ, block the phosphorylation of IκBα, prevent NF-κB entering into the nucleus, and then decrease the release of inflammatory mediators.